Search clinical trials for: Angiotensin II

Total 8529 results

University of Erlangen-Nürnberg Medical School
Bristol-Myers Squibb

Completed

Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia

Hypercholesterolemia

Germany
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

Hypertension

Belgium, Turkey, Hungary, United States, Italy, India, Poland, France, South Africa, Brazil
Novartis

Completed

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

Hypertension | Metabolic Syndrome

Germany, Switzerland
Boehringer Ingelheim

Completed

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients

Hypertension
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Healthy

India
Kagoshima University

Unknown

Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study) (KACT)

Hypertension | Obesity

Japan
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Hypertension

Hypertension

Turkey
Odense University Hospital

Unknown

Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

Atrial Fibrillation | Aortic Valve Stenosis | Left Ventricular Hypertrophy

Denmark
Regional Hospital Holstebro

Completed

The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension

Essential Hypertension

Denmark
Sanofi
Bristol-Myers Squibb

Completed

APROVE : Irbesartan in Hypertension

Hypertension

Algeria
Sanofi
Bristol-Myers Squibb

Completed

Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

Hypertension

Tunisia
Regional Hospital Holstebro

Completed

The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.

Healthy

Denmark
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

Vasodilatory Shock

China
Palatin Technologies, Inc

Recruiting

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease (BREAKOUT)

Kidney Disease

United States
Kyoto University, Graduate School of Medicine

Completed

Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)

Hypertension | Obstructive Sleep Apnea

Japan
The George Institute

Completed

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease (CLARITY)

COVID-19 | Coronavirus Disease 2019

Australia, India
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE) (ARCADE)

Ehlers-Danlos Syndrome, Vascular Type

France
Boehringer Ingelheim

Completed

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

Hypertension

Belgium, Canada, Colombia, Czechia, Ecuador, Indonesia, Jordan, Lebanon, Mexico, Turkey, Venezuela, Yemen
University of California, Los Angeles
California HIV/AIDS Research Program

Completed

HIV and Fat Accumulation (MATH)

HIV Infection

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions

Hypertension

United States
Boehringer Ingelheim

Completed

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

Hypertension
Novartis

Completed

To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus

Proteinuria | Microalbuminuria

Egypt
Novartis

Completed

Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

Diastolic Dysfunction, Symptomatic Heart Failure

Switzerland, Germany
Kumamoto University

Terminated

Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study

Hypertension

Japan
Boehringer Ingelheim

Completed

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Hypertension
Novartis

Completed

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

Hypertension

Germany
Novartis

Completed

A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure

Hypertension

Switzerland
University of Campania "Luigi Vanvitelli"

Completed

Telmisartan in Haemodialysis Patients With Chronic Heart Failure

Heart Failure, Congestive

Italy
Novartis

Completed

Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.

Healthy

United States
Novartis

Completed

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

Healthy

India
Takeda

Completed

A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

Hypertension

Japan
Palo Alto Veterans Institute for Research
Medtronic; James Cook University, Queensland, Australia

Completed

Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms (TEDY)

Abdominal Aortic Aneurysm

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Hypertension

United States
Ain Shams University

Completed

Chronopharmacology of Valsartan in Normotensive Subjects

Healthy Normotensive Volunteers

Egypt
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Drug-drug Interaction of SP2086 and Valsartan

Type 2 Diabetes

China
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

Congestive Heart Failure

Netherlands, Portugal, Spain, United States, Belgium, Italy, Argentina, Brazil, Canada, France, Germany, Mexico, South Africa, Sweden, Australia, Russian Federation, Poland, Czech Republic, Denmark, Ireland, Hungary, Switzerland, Gr... and more
Karin Skov
AstraZeneca; University of Aarhus

Unknown

Danish Hypertension Prevention Project - DHYPP

Hypertension

Denmark
Fundación Cardiovascular de Colombia
AstraZeneca

Terminated

Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects (ARAMIA)

Obesity | Glucose Intolerance

Colombia
Seung-Jung Park
Novartis

Completed

Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent (VAL-SUPPRES)

Coronary Artery Disease

Korea, Republic of
Osaka City University

Completed

Prevention of CHOP-induced Chronic Cardiotoxicity

Non-Hodgkin's Lymphoma

Japan
Sanofi
Bristol-Myers Squibb

Completed

The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension

Hypertension

United States
Steno Diabetes Center Copenhagen

Completed

Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria

Type 2 Diabetes | Microalbuminuria

Denmark
Rambam Health Care Campus

Unknown

Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs

NIDDM

Israel
Celltrion Pharm, Inc.

Completed

A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea

Essential Hypertension

Korea, Republic of
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The DDI Study of SP2086 and Valsartan

Type 2 Diabetes

China
Takeda

Completed

A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet

Hypertension

Japan
LG Life Sciences

Completed

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
University of California, Los Angeles
The Campbell Foundation

Completed

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

Endothelial Dysfunction

United States

3

Subscribe